Copyright
©The Author(s) 2017.
World J Gastroenterol. May 28, 2017; 23(20): 3675-3683
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3675
Published online May 28, 2017. doi: 10.3748/wjg.v23.i20.3675
Table 1 Clinical characteristics of hepatocellular carcinoma and paired adjacent tissues n (%)
| Clinical variable | No. of patients |
| No. of patients | 47 |
| Age, yr, mean ± SD | 56 ± 11 |
| Sex | |
| Female | 18 (38.3) |
| Male | 29 (61.70) |
| Serum AFP, ng/mL | |
| ≤ 400 | 36 (76.60) |
| > 400 | 11 (23.40) |
| HBV infection | |
| Positive | 38 (80.9) |
| Negative | 3 (19.1) |
| Largest tumor diameter, cm | 5.7 ± 3.4 |
| TNM stage | |
| I | 2 (4.25) |
| II | 30 (63.83) |
| III | 15 (31.92) |
| Lymph node metastatic | |
| Positive | 20 (42.55) |
| Negative | 27 (47.45) |
- Citation: Ju LL, Chen L, Li JH, Wang YF, Lu RJ, Bian ZL, Shao JG. Effect of NDC80 in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(20): 3675-3683
- URL: https://www.wjgnet.com/1007-9327/full/v23/i20/3675.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i20.3675